Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-01-06 @ 3:06 PM
Study NCT ID:
NCT06694805
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2024-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
Sponsor:
ViiV Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-02
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-17
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-06-19
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-15
First Submit QC Date:
None
Study First Post Date:
2024-11-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED